Rickettsia conorii
Rickettsia conorii is a Gram-negative, obligate intracellular bacterium of the genus Rickettsia that is the causative agent of Mediterranean spotted fever, also known as Boutonneuse fever. This bacterium is transmitted to humans by the bite of a tick, specifically the brown dog tick (Rhipicephalus sanguineus).
Taxonomy[edit]
Rickettsia conorii belongs to the genus Rickettsia, which is a part of the phylum Proteobacteria. This genus is further divided into four groups: the spotted fever group, the typhus group, the Rickettsia bellii group, and the Rickettsia canadensis group. Rickettsia conorii is a member of the spotted fever group.
Pathogenesis[edit]
The bacterium is transmitted to humans through the bite of an infected tick. Once inside the human body, Rickettsia conorii infects the endothelial cells lining the blood vessels, causing vasculitis, a condition characterized by inflammation of the blood vessels. This results in the characteristic symptoms of Mediterranean spotted fever, which include fever, headache, and a rash.
Clinical Presentation[edit]
The primary symptom of infection with Rickettsia conorii is Mediterranean spotted fever, which is characterized by fever, headache, and a rash. The rash typically begins on the extremities and spreads to the trunk. In severe cases, the disease can cause complications such as meningitis, encephalitis, and pneumonia.
Diagnosis and Treatment[edit]
Diagnosis of Rickettsia conorii infection is typically based on clinical presentation and confirmed by laboratory testing. Treatment usually involves antibiotics, with doxycycline being the drug of choice.
Prevention[edit]
Prevention of Rickettsia conorii infection primarily involves avoiding tick bites through the use of insect repellents and protective clothing.
See Also[edit]
Rickettsia conorii[edit]
-
Rickettsia conorii in Vero
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
